The list of proposed molecular cancer-specific markers encompasses point mutations in BRAF and RAS; RET/PTC and PAX8/PPARγ rearrangements; sets of miRNAs, for which significant changes in expression have been established for different types of neoplasms; transcripts of protein-coding genes as well as their products, etc. [33–35]. This evidence concerns the gene PAX8 and cancer.